Careers Contact Us
logo
Precision Biosciences Logo
  • Who We Are
    • Who We Are
      • Our History
      • Mission & Values
    • Our Team
      • Leadership
      • Board of Directors
      • Scientific Advisors
    • Careers
  • ARCUS Genome Editing
    • ARCUS Genome Editing
    • Scientific Publications
  • Pipeline
    • Overview
    • PBGENE-HBV
    • Clinical Trials
    • Expanded Access
  • Investors
    • Events & Presentations
    • Press Releases
    • Corporate Deck
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Sustainability
    • Investor FAQs
  • Partnering
  • Search

Maurissa Messier

Effective Cell Dose and Functional Attributes of Azercabtagene Zapreleucel (Azer-cel; PBCAR0191) Associated with Allogeneic CAR T-Cell Safety and Efficacy in Patients with Relapsed/Refractory B-Cell Lymphoma


by Maurissa Messier

Precise and simultaneous quantification of mitochondrial DNA heteroplasmy and copy number by digital PCR


by Maurissa Messier

AAV-meganuclease-mediated gene targeting achieves efficient and sustained transduction in newborn and infant macaque liver


by Maurissa Messier

Effective Cell Dose and Functional Attributes of Azercabtagene Zapreleucel (azer-cel; PBCAR0191) Associate with Allogeneic CAR T-Cell Safety and Efficacy in Patients with Relapsed/Refractory B-Cell Lymphoma


by Maurissa Messier

Treating Transthyretin Amyloidosis via Adeno-Associated Virus Vector Delivery of Meganucleases


by Maurissa Messier

Targeting Hepatitis B cccDNA with a Sequence-Specific ARCUS Nuclease to Eliminate Hepatitis B Virus In Vivo


by Maurissa Messier

ARCUS gene editing of Apolipoprotein C3 results in substantial reduction in serum triglycerides in vivo


by Maurissa Messier

Specific elimination of m.3243A>G mutant mitochondrial DNA using mitoARCUS in cultured cells and a novel xenograft mouse model


by Maurissa Messier

Targeting the Hepatitis B cccDNA with a Sequence-Specific ARCUS Nuclease to Eliminate Hepatitis B Virus In Vivo


by Maurissa Messier

Mitochondrial Targeted Meganuclease as a Platform to Eliminate Mutant mtDNA In Vivo


by Maurissa Messier

Rho 1-2 Meganuclease, an Allele-Specific Gene Editing Therapy, Rejuvenates Rod Photoreceptor Structure and Function in a Pig Model of adRP


by Maurissa Messier

Translation of an AAV-Delivered Gene Editing Approach for Transthyretin Amyloidosis in Animal Models


by Maurissa Messier

Long-Term Stable Reduction of Low-Density Lipoprotein in Nonhuman Primates Following In Vivo Genome Editing of PCSK9


by Maurissa Messier

Preliminary Safety and Efficacy of PBCAR0191, an Allogeneic, Off-the-Shelf CD19-Targeting CAR-T Product, in Relapsed/Refractory (r/r) CD19+ NHL


by Maurissa Messier

Precision Biosciences Logo
Contact Info
919.314.5512

Contact Us
Partner with Us
Career Opportunities

Learn More

ARCUS Genome Editing
Pipeline

heading

Our Mission
Our Team

Policies

Terms of Use
Privacy Notices
Disclaimer
Cookie Policy

©2021 Precision BioSciences

"This website uses cookies for functionality, analytics, personalized content, and ads. By clicking the “Accept All Cookies” or "Accept Non-Essential Cookies" button, you consent to our use of non-essential cookies for a tailored website experience, and to share your browsing information with third-parties. For more detailed information on our use of Cookies, please click the “Cookie Policy” button"